Effects of combined antiviral therapy on asymptomatic mixed cryoglobulinemia in naive patients with chronic hepatitis C virus infection: A preliminary study

Digestive Diseases and Sciences

Volumn 50, Issue 12, 2005, Pages 2344-2347

  D'Amico, Emilio ^a,d   Chincoli, Caterina ^a   Cacciatore, Pierluigi ^a   Di Pasqua, Gabriella ^a   Cosentino, Luana ^a   Riario Sforza, Giuseppe ^a   Pennese, Ernesta ^b   Capani, Fabio ^c   Palazzi, Carlo ^b  

^a SPIRITO SANTO HOSPITAL   (Italy)

^b Villa Pini Clinic   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d NONE   (Italy)

Author keywords

Cryoglobulinemia; Cryoglobulins; Hepatitis C; Interferon; Ribavirin

Indexed keywords

ALPHA INTERFERON; RIBAVIRIN;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; ANTIVIRAL AGENTS; CRYOGLOBULINEMIA; CRYOGLOBULINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RIBAVIRIN; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VIRAL LOAD;

EID: 30844446978     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-3059-x     Document Type: Article

References (24)

1. Cacoub P, Costedoat-Chalumeau N, Lidove O, Alric L: Cryoglobulinemia vasculitis. Curr Opin Rheumatol 14:29-35, 2002
2. Della Rossa A, Tavoni A, Baldini C, Bombardieri S: Treatment of chronic hepatitis C infection with cryoglobulinemia. Curr Opin Rheumatol 14:231-237, 2002
3. Vassilopoulos D, Calabrese LH: Rheumatic manifestations of hepatitis C infection. Curr Rheumatol Rep 5:200-204, 2003
4. Ferri C, Sebastiani M, Giuggioli D, Cazzato M, Longombardo G, Antonelli A, Puccini R, MIchelassi C, Zignego AL: Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 33:355-374, 2004
5. Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, Grippon P, Hoang C, Valla D, Piette JC: Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 106:1291-1300, 1994
6. Ferri C, Marzo E, Longobardo G, Lombardini F, La Civita L, Vanacore R, Liberati AM, Gerli R, Greco F, Moretti A: Interferon-α in mixed cryoglobulinemia patients. Blood 81:1132-1136, 1993
7. Mazzaro C, Carniello GS, Colle R, Doretto P, Mazzi G, Crovatto M, Santini GF, Tulissi P, Gregoretti M, Mazzoran L, Russo A, Silvestri F, Pozzato G: Interferon therapy in HCV-positive mixed cryoglobulinemia: viral and host factors contributing to efficacy of the therapy. Ital J Gastroenterol Hepatol 29:343-350, 1997
8. Casato M, Agnello V, Pucillo LP, Knight GB, Leoni M, Del Vecchio S, Mazzilli C, Antonelli G, Bonomo L: Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection. Blood 90:3865-3873, 1997
9. Naarendorp M, Kallemuchikkal U, Nuovo GJ, Gorevic PD: Long term efficacy of interferon-α for extra-hepatic disease associated with hepatitis C virus infection. J Rheumatol 28:2466-2473, 2001
10. Willson RA: The benefit of long-term interferon alfa therapy for symptomatic mixed cryoglobulinemia (cutaneous vasculitis/membranoproliferative glomerulonephritis) associated with chronic hepatitis C infection. J Clin Gastroenterol 33:137-140, 2001
11. Donada C, Crucitti A, Donadon V, Chemello L, Alberti A: Interferon and ribavirin combination therapy in patients with chronic hepatitis C and mixed cryoglobulinemia. Blood 92:2983-2984, 1998
12. Calleja JL, Albillos A, Moreno-Otero R, Rossi I, Cacho G, Domper F, Yebra M, Escartin P: Sustained response to interferon-alpha or to interpheron-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia. Aliment Pharmacol Ther 13:1179-1186, 1999
13. Zuckerman E, Keren D, Slobodin G, Rosner I, Rozembaum M, Toubi E, Sabo E, Tsykounov I, Naschitz JE, Yeshurun D: Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alfa. J Rheumatol 27:2172-2178, 2000
14. Mazzaro C, Zorat F, Comar C, Nascimben F, Bianchini D, Baracetti S, Donada C, Donadon V, Pozzato G: Interferon plus ribavirin in patients with hepatitis C virus positive mixed cryoglobulinemia resistant to interferon. J Rheumatol 30:1775-1781, 2003
15. Cacoub P, Ratziu V, Myers RP, Ghillani P, Piette JC, Moussalli J, Poynard T, Multivirc Group, for the Multivirc Group: Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C. J Hepatol 36:812-818, 2002
16. Garini G, Allegri L, Carnevali L, Catellani W, Manganelli P, Buzio C: Interferon-alfa in combination with ribavirin as initial treatment for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis. Am J Kidney Dis 38:E35, 2001
17. Sabry AA, Sobh MA, Sheaashaa HA, Kudesia J, Wild G, Fox S, Wagner BE, Irving WL, Grabowska A, El-Nahas AM. Effect of combination therapy (ribavirin and interferon) in HCV-related glomerulopathy. Nephrol Dial Transplant 17:1924-1930, 2002
18. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kieman TW, Wollman J: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431-435, 1981
19. Pham TH, MacParland SA, Mulrooney PM, Cooksley H, Naoumov NV, Michalak TI: Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 78:5867-5874, 2004
20. Kimyai-Asadi A, Gohar K, Kang P, Usman A, Zenemberg R, Jih MH: Mixed cryoglobulinemia secondary to interferon therapy for hepatitis C: case report and review of the literature. J Drugs Dermatol 1:72-75, 2002
21. Fadda P, La Civita L, Zignego AL, Ferri C: Epatite C e artrite. Studio clinico-sierologico dell'artrite in pazienti con e senza sindrome crioglobulinemica. Reumatismo 54:316-323, 2002
22. Wilson LE, Widman D, Dikman SH, Gorevic PD: Autoimmune disease complicating antiviral therapy for hepatitis C virus infection. Semin Arthritis Rheum 32:163-173, 2002
23. Olivieri I, Palazzi C, Padula A: Hepatitis C virus infection and arthritis. Rheum Dis Clin North Am 29:111-122, 2003
24. Palazzi C, Olivieri I, Cacciatore P, Pennese E, D'Amico E: Management of hepatitis C virus-related arthritis. Expert Opin Pharmacother 6:27-34, 2005